Variant report
Variant | nsv598539 |
---|---|
Chromosome Location | chr5:69742545-69781694 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:156)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:2)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | BATF | chr5:69753018-69753328 | GM12878 | blood: | n/a | n/a |
2 | BCL11A | chr5:69752885-69753406 | GM12878 | blood: | n/a | n/a |
3 | BCL11A | chr5:69753005-69753291 | GM12878 | blood: | n/a | n/a |
4 | CEBPB | chr5:69781664-69782080 | K562 | blood: | n/a | n/a |
5 | CTCF | chr5:69769552-69769736 | A549 | lung: | n/a | n/a |
6 | CTCF | chr5:69745567-69745694 | LNCaP | prostate: | n/a | n/a |
7 | CTCF | chr5:69781638-69781972 | K562 | blood: | n/a | n/a |
8 | CTCF | chr5:69769418-69769768 | K562 | blood: | n/a | n/a |
9 | CTCF | chr5:69752751-69752752 | GM10248 | blood: | n/a | n/a |
10 | CTCF | chr5:69769472-69769783 | K562 | blood: | n/a | n/a |
11 | CTCF | chr5:69769550-69769621 | Spleen_OC | spleen: | n/a | n/a |
12 | CTCF | chr5:69781660-69782018 | K562 | blood: | n/a | n/a |
13 | CTCF | chr5:69781693-69781995 | K562 | blood: | n/a | n/a |
14 | CTCF | chr5:69769416-69769782 | A549 | lung: | n/a | n/a |
15 | CTCF | chr5:69769471-69769899 | K562 | blood: | n/a | n/a |
16 | CTCF | chr5:69752763-69752823 | GM10248 | blood: | n/a | n/a |
17 | EBF1 | chr5:69760028-69760348 | GM12878 | blood: | n/a | n/a |
18 | EBF1 | chr5:69753017-69753402 | GM12878 | blood: | n/a | n/a |
19 | EP300 | chr5:69769573-69769772 | GM12878 | blood: | n/a | n/a |
20 | ESR1 | chr5:69754995-69755378 | T-47D | breast: | n/a | n/a |
21 | ESR1 | chr5:69754993-69755406 | T-47D | breast: | n/a | n/a |
22 | FOSL2 | chr5:69773830-69774443 | HepG2 | liver: | n/a | n/a |
23 | FOSL2 | chr5:69775073-69775522 | HepG2 | liver: | n/a | n/a |
24 | FOSL2 | chr5:69765809-69766245 | HepG2 | liver: | n/a | n/a |
25 | FOSL2 | chr5:69769329-69770179 | HepG2 | liver: | n/a | chr5:69769812-69769823 |
26 | FOSL2 | chr5:69775936-69776177 | HepG2 | liver: | n/a | n/a |
27 | FOSL2 | chr5:69772810-69773402 | HepG2 | liver: | n/a | n/a |
28 | FOSL2 | chr5:69769405-69770159 | HepG2 | liver: | n/a | chr5:69769812-69769823 |
29 | FOSL2 | chr5:69771193-69771662 | HepG2 | liver: | n/a | chr5:69771428-69771436 |
30 | FOSL2 | chr5:69768510-69768836 | HepG2 | liver: | n/a | n/a |
31 | FOXA1 | chr5:69774475-69774785 | HepG2 | liver: | n/a | n/a |
32 | FOXA1 | chr5:69755066-69755396 | HepG2 | liver: | n/a | n/a |
33 | FOXA1 | chr5:69745291-69745819 | HepG2 | liver: | n/a | n/a |
34 | FOXA1 | chr5:69769080-69770295 | HepG2 | liver: | n/a | n/a |
35 | GABPA | chr5:69781476-69781600 | Hela-S3 | cervix: | n/a | n/a |
36 | GATA2 | chr5:69745373-69745807 | K562 | blood: | n/a | chr5:69745625-69745637 chr5:69745627-69745635 |
37 | GATA2 | chr5:69766617-69767051 | K562 | blood: | n/a | n/a |
38 | HEY1 | chr5:69769468-69769819 | HepG2 | liver: | n/a | n/a |
39 | IRF4 | chr5:69759971-69760374 | GM12878 | blood: | n/a | n/a |
40 | IRF4 | chr5:69752835-69753489 | GM12878 | blood: | n/a | n/a |
41 | IRF4 | chr5:69769504-69769852 | GM12878 | blood: | n/a | n/a |
42 | IRF4 | chr5:69769457-69769813 | GM12878 | blood: | n/a | n/a |
43 | IRF4 | chr5:69752791-69753683 | GM12878 | blood: | n/a | n/a |
44 | JUND | chr5:69770260-69770451 | HepG2 | liver: | n/a | n/a |
45 | JUND | chr5:69769533-69769722 | HepG2 | liver: | n/a | n/a |
46 | JUND | chr5:69778416-69778539 | HepG2 | liver: | n/a | n/a |
47 | JUND | chr5:69769502-69769813 | HepG2 | liver: | n/a | n/a |
48 | JUND | chr5:69769900-69770177 | HepG2 | liver: | n/a | n/a |
49 | JUND | chr5:69770011-69770130 | HepG2 | liver: | n/a | n/a |
50 | JUND | chr5:69771278-69771464 | HepG2 | liver: | n/a | chr5:69771428-69771436 |
No data |
No data |
(count:2 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-SMN2-2 | chr5:69745463-69746180 | ENSG00000269983.1 |
2 | lnc-NAIP-2 | chr5:69776697-69777165 | NONHSAT101978 |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000237075 | TF binding region |
ENSG00000250687 | TF binding region |
ENSG00000269983 | TF binding region |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs79591973 | chr5:69742545-69742546 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs566106077 | chr5:69743577-69743578 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs369934783 | chr5:69743833-69743834 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs539942196 | chr5:69743887-69743888 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs372920488 | chr5:69745241-69745242 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs573691863 | chr5:69745409-69745410 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
7 | rs374333686 | chr5:69745410-69745411 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
8 | rs558262144 | chr5:69746274-69746275 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs111708046 | chr5:69746315-69746316 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs570662354 | chr5:69746609-69746610 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs576539937 | chr5:69748364-69748365 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs554868993 | chr5:69748561-69748562 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs535459742 | chr5:69748896-69748897 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs537439714 | chr5:69748933-69748934 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs555752675 | chr5:69748937-69748938 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs79005997 | chr5:69753111-69753112 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
17 | rs377233943 | chr5:69753120-69753121 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
18 | rs369739445 | chr5:69753186-69753187 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
19 | rs202096607 | chr5:69753238-69753239 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
20 | rs531251206 | chr5:69753499-69753500 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
21 | rs561483340 | chr5:69753969-69753970 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
22 | rs529604820 | chr5:69753991-69753992 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
23 | rs547745233 | chr5:69754076-69754077 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
24 | rs62371812 | chr5:69754929-69754930 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs199515205 | chr5:69755004-69755005 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
26 | rs192070142 | chr5:69755087-69755088 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
27 | rs534446143 | chr5:69755144-69755145 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
28 | rs138403865 | chr5:69755157-69755158 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
29 | rs577270626 | chr5:69755180-69755181 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
30 | rs538305504 | chr5:69755195-69755196 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
31 | rs570166338 | chr5:69755202-69755203 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
32 | rs556615208 | chr5:69755235-69755236 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
33 | rs537501659 | chr5:69755283-69755284 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
34 | rs477367 | chr5:69755950-69755951 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs515757 | chr5:69756041-69756042 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs555814394 | chr5:69756108-69756109 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs76449491 | chr5:69756225-69756226 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs377542468 | chr5:69756236-69756237 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs567525803 | chr5:69758745-69758746 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs199994322 | chr5:69759018-69759019 | Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
41 | rs207725 | chr5:69759186-69759187 | Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
42 | rs112989046 | chr5:69760992-69760993 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs78689745 | chr5:69761189-69761190 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs75862166 | chr5:69761192-69761193 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs535771280 | chr5:69762234-69762235 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs377401260 | chr5:69762332-69762333 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs200638600 | chr5:69762550-69762551 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs371718688 | chr5:69762588-69762589 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs553769065 | chr5:69763755-69763756 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs572248753 | chr5:69763906-69763907 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Cancer | 20164919 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Ovarian cancer | 21781307 | CNVD |
DNA damage stimulus | 22844521 | CNVD |
DNA repair | 22844521 | CNVD |
Breast cancer | 21785460 | CNVD |
Spinal muscular atrophy | 22422766 | CNVD |
Spinal muscular atrophy | 22558076 | CNVD |
Spinal muscular atrophy | 21320981 | CNVD |
Spinal muscular atrophy | 21762474 | CNVD |
Cancer | 16751803 | CNVD |
Intellectual disability | 22102821 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Breast cancer | 17603634 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Melanoma | 18172304 | CNVD |
Glioma | 20126413 | CNVD |
Breast cancer | 22032731 | CNVD |
Prostate cancer | 21965145 | CNVD |
Esophageal cancer | 20955586 | CNVD |
Congenital anomalies of the kidney and urinary tract | 18694510 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Breast cancer | 17393978 | CNVD |
Cancer | 21359685 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
adenomatous polyposis | 22470819 | CNVD |
Cancer | 22429812 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Liposarcoma | 21253554 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Breast cancer | 21858162 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Leukemia | 17361228 | CNVD |
Myelodysplastic syndrome | 18508791 | CNVD |
5q-syndrome | 17576883 | CNVD |
Gastric cancer | 17908304 | CNVD |
Lung cancer | 16740712 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Oral cancer | 21386901 | CNVD |
Bladder cancer | 21909424 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Barrett''s syndrome | 19417022 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 17133270 | CNVD |
Breast cancer | 19602461 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Bipolar disorder | 18458673 | CNVD |
Thyroid cancer | 19087340 | CNVD |
abnormal development | 18461090 | CNVD |
Merkel cell carcinoma | 19020549 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Prostate cancer | 18632612 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Breast cancer | 21045282 | CNVD |
Chronic lymphocytic leukemia | 18922857 | CNVD |
Myelodysplastic syndrome | 18663149 | CNVD |
Spinal muscular atrophy | 15981080 | CNVD |
Spinal muscular atrophy | 18839960 | CNVD |
Spinal muscular atrophy | 19716110 | CNVD |
Sezary syndrome | 18413736 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Breast cancer | 21990379 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Apoptosis | 19488400 | CNVD |
Breast cancer | 22048815 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Acute monocytic leukemia | 16498392 | CNVD |
Colorectal cancer | 20459617 | CNVD |
Gastric adenocarcinoma | 19115996 | CNVD |
Spinal muscular atrophy | 17160897 | CNVD |
Spinal muscular atrophy | 17668391 | CNVD |
Spinal muscular atrophy | 17668395 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
craniofacial dysmorphism | 21918468 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Prostate cancer | 16461572 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
Pseudo-TORCH syndrome | 20727516 | CNVD |
Medullary thyroid carcinoma | 18765511 | CNVD |
Obesity | 21131291 | CNVD |
early-passage human iPS cells | 21368824 | CNVD |
Breast cancer | 21364760 | CNVD |
Mental retardation | 20877625 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
Non-syndromic sensorineural hearing loss | 17289997 | CNVD |
Spinal muscular atrophy | 17647030 | CNVD |
Spinal muscular atrophy | 20937953 | CNVD |
Spinal muscular atrophy | 20442745 | CNVD |
Spinal muscular atrophy | 21227393 | CNVD |
Breast cancer | 21509527 | CNVD |
Disease | 19212409 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr5:69729400-69745200 | Weak transcription | HUES64 Cell Line | embryonic stem cell |
2 | chr5:69734200-69745000 | Weak transcription | Fetal Stomach | stomach |
3 | chr5:69734400-69744000 | Weak transcription | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
4 | chr5:69734600-69745000 | Weak transcription | Fetal Intestine Small | intestine |
5 | chr5:69734800-69745000 | Weak transcription | Fetal Thymus | thymus |
6 | chr5:69738800-69744000 | Weak transcription | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
7 | chr5:69738800-69748800 | Weak transcription | Primary neutrophils fromperipheralblood | blood |
8 | chr5:69748800-69749000 | Enhancers | Primary neutrophils fromperipheralblood | blood |
9 | chr5:69754800-69755400 | Enhancers | Primary monocytes fromperipheralblood | blood |
10 | chr5:69755000-69755400 | Enhancers | Monocytes-CD14+_RO01746 | blood |
11 | chr5:69755400-69758600 | Weak transcription | Primary monocytes fromperipheralblood | blood |
12 | chr5:69755400-69758600 | Weak transcription | Monocytes-CD14+_RO01746 | blood |
13 | chr5:69758600-69759000 | Active TSS | Primary monocytes fromperipheralblood | blood |
14 | chr5:69758600-69759000 | Enhancers | Primary B cells from peripheral blood | blood |
15 | chr5:69758600-69759000 | Active TSS | Monocytes-CD14+_RO01746 | blood |
16 | chr5:69758600-69759600 | Active TSS | Primary neutrophils fromperipheralblood | blood |
17 | chr5:69759000-69767800 | Weak transcription | Primary monocytes fromperipheralblood | blood |
18 | chr5:69759600-69760800 | Weak transcription | Primary neutrophils fromperipheralblood | blood |
19 | chr5:69760800-69761200 | Enhancers | Primary neutrophils fromperipheralblood | blood |